Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab

OBJECTIVES: Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways have demonstrated survival improvements in multiple advanced cancers, but also cause immune-related adverse events (IRAEs). IRAEs wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Rheum Dis
Asıl Yazarlar: Cappelli, Laura C, Gutierrez, Anna Kristina, Baer, Alan N, Albayda, Jemima, Manno, Rebecca L, Haque, Uzma, Lipson, Evan J, Bleich, Karen B, Shah, Ami A, Naidoo, Jarushka, Brahmer, Julie R, Le, Dung, Bingham, Clifton O
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5333990/
https://ncbi.nlm.nih.gov/pubmed/27307501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2016-209595
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller